Barry Russo, CEO, The Center for Cancer and Blood Disorders, discusses ways to overcome financial toxicities associated with the cost of cancer care.
ctDNA Monitoring in Breast Cancer Treatment: Early Signs and Future Directions
Mridula George, MD, discussed a study investigating ctDNA monitoring during neoadjuvant therapy of breast cancer.
Read More
Advancing Melanoma Treatment: Hamid on Lifileucel's Role
In this episode of Targeted Talks, Omid Hamid, MD, discusses data supporting the use of lifileucel for the treatment of advanced melanoma.
Listen
New CAR T Therapy for ALL Earns FDA Orphan and Rare Pediatric Drug Designations
The CAR T-cell therapy UCART22 has been granted orphan drug designation and rare pediatric drug designation from the FDA for the treatment of acute lymphoblastic leukemia.
Transforming Prostate Cancer Care Through Personalized Medicine
Adam Weiner, MD, discusses his journey toward becoming an oncologist with a focus in urology in this episode of Emerging Experts.
Desai and Participants Differentiate BPDCN From Other Diagnoses
During a Case-Based Roundtable® event, Pinkal Desai, MD, MPH, discusses the presentation of blastic plasmacytoid dendritic cell neoplasm vs other diseases in a patient case.
FDA ODAC Votes Unanimously to Mandate Phase Assessments in NSCLC Perioperative Regimens
The FDA’s Oncologic Drugs Advisory Committee convened to assess the need for rigorous trial designs evaluating perioperative regimens in resectable non–small cell lung cancer.